Keler T - Search Results

1

Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210.

Watanabe M, Wallace PK, Keler T, Deo YM, Akewanlop C, Hayes DF. Watanabe M, et al. Among authors: keler t. Breast Cancer Res Treat. 1999 Feb;53(3):199-207. doi: 10.1023/a:1006145507567. Breast Cancer Res Treat. 1999. PMID: 10369066

2

Bispecific antibody-dependent cellular cytotoxicity of HER2/neu-overexpressing tumor cells by Fc gamma receptor type I-expressing effector cells.

Keler T, Graziano RF, Mandal A, Wallace PK, Fisher J, Guyre PM, Fanger MW, Deo YM. Keler T, et al. Cancer Res. 1997 Sep 15;57(18):4008-14. Cancer Res. 1997. PMID: 9307286

3

Bispecific molecules directed to the Fc receptor for IgA (Fc alpha RI, CD89) and tumor antigens efficiently promote cell-mediated cytotoxicity of tumor targets in whole blood.

Deo YM, Sundarapandiyan K, Keler T, Wallace PK, Graziano RF. Deo YM, et al. Among authors: keler t. J Immunol. 1998 Feb 15;160(4):1677-86. J Immunol. 1998. PMID: 9469424

4

Characterization of a novel bispecific antibody that mediates Fcgamma receptor type I-dependent killing of tumor-associated glycoprotein-72-expressing tumor cells.

Russoniello C, Somasundaram C, Schlom J, Deo YM, Keler T. Russoniello C, et al. Among authors: keler t. Clin Cancer Res. 1998 Sep;4(9):2237-43. Clin Cancer Res. 1998. PMID: 9748144

5

Development of a trispecific antibody conjugate that directs two distinct tumor-associated antigens to CD64 on myeloid effector cells.

Somasundaram C, Sundarapandiyan K, Keler T, Deo YM, Graziano RF. Somasundaram C, et al. Among authors: keler t. Hum Antibodies. 1999;9(1):47-54. Hum Antibodies. 1999. PMID: 10331185

6

Differential effect of cytokine treatment on Fc alpha receptor I- and Fc gamma receptor I-mediated tumor cytotoxicity by monocyte-derived macrophages.

Keler T, Wallace PK, Vitale LA, Russoniello C, Sundarapandiyan K, Graziano RF, Deo YM. Keler T, et al. J Immunol. 2000 Jun 1;164(11):5746-52. doi: 10.4049/jimmunol.164.11.5746. J Immunol. 2000. PMID: 10820252

7

Bispecific antibody-mediated destruction of Hodgkin's lymphoma cells.

Sundarapandiyan K, Keler T, Behnke D, Engert A, Barth S, Matthey B, Deo YM, Graziano RF. Sundarapandiyan K, et al. Among authors: keler t. J Immunol Methods. 2001 Feb 1;248(1-2):113-23. doi: 10.1016/s0022-1759(00)00347-1. J Immunol Methods. 2001. PMID: 11223073

8

Bispecific antibody-targeted phagocytosis of HER-2/neu expressing tumor cells by myeloid cells activated in vivo.

Wallace PK, Kaufman PA, Lewis LD, Keler T, Givan AL, Fisher JL, Waugh MG, Wahner AE, Guyre PM, Fanger MW, Ernstoff MS. Wallace PK, et al. Among authors: keler t. J Immunol Methods. 2001 Feb 1;248(1-2):167-82. doi: 10.1016/s0022-1759(00)00350-1. J Immunol Methods. 2001. PMID: 11223077 Clinical Trial.

9

Fc gamma RI blockade and modulation for immunotherapy.

Wallace PK, Keler T, Guyre PM, Fanger MW. Wallace PK, et al. Among authors: keler t. Cancer Immunol Immunother. 1997 Nov-Dec;45(3-4):137-41. doi: 10.1007/s002620050416. Cancer Immunol Immunother. 1997. PMID: 9435857 Free PMC article.

10

Targeting weak antigens to CD64 elicits potent humoral responses in human CD64 transgenic mice.

Keler T, Guyre PM, Vitale LA, Sundarapandiyan K, van De Winkel JG, Deo YM, Graziano RF. Keler T, et al. J Immunol. 2000 Dec 15;165(12):6738-42. doi: 10.4049/jimmunol.165.12.6738. J Immunol. 2000. PMID: 11120792

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page